Skip to Main Content

Author Details

Dana J Lukin
Jill Roberts Center for IBD
2000
57
17
PMIDPaper TitleJournal TitlePublished Year
37646564The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease.J Clin Gastroenterol2024
36191274The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.Am J Gastroenterol2023
37601744<i>Mycobacterium avium</i> subspecies <i>paratuberculosis</i> (MAP) and Crohn's disease: the debate continues.Transl Gastroenterol Hepatol2023
35522225Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study.Inflamm Bowel Dis2023
37350629Shifting the Inflammatory Balance in Ulcerative Colitis Through Diet: A Mediterranean Diet Pattern is Associated with Improvements in Dysbiosis and Disease Activity.J Crohns Colitis2023
37016720The Impact of Confounders on Symptom-Endoscopic Discordances in Crohn's Disease.Crohns Colitis 3602023
37145193PRO Tips: First-Rate Guidance for Second-Line Therapy After Tumor Necrosis Factor-Alpha Exposure in Patients with Crohn's Disease.Dig Dis Sci2023
36421052Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.Inflamm Bowel Dis2023
36322790Increased Primary Bile Acids with Ileocolonic Resection Impact Ileal Inflammation and Gut Microbiota in Inflammatory Bowel Disease.J Crohns Colitis2023
36258306Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach.J Gastroenterol Hepatol2023
33039584Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.Clin Gastroenterol Hepatol2022
35441160Joint Disease Activity in Inflammatory Bowel Disease-associated Peripheral Spondyloarthritis Stratifies Therapeutic Response.Gastro Hep Adv2022
35416799Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel.Am J Gastroenterol2022
36327029Article Topic: Positioning Ulcerative Colitis Therapies in 2022 and Beyond.Curr Gastroenterol Rep2022
36348637COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study.Therap Adv Gastroenterol2022
36156920Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease.World J Gastroenterol2022
33798711Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol2022
35180182A Quality Improvement Initiative Is Associated With Reduced Time to Administer Biologics and Small Molecules and Emergency Room Visits in Inflammatory Bowel Disease.J Clin Gastroenterol2022
34896283Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination.Clin Gastroenterol Hepatol2022
34033922Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability.Clin Gastroenterol Hepatol2022
32565012Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease.Gastroenterology2021
33741315Bacterial Swarmers Enriched During Intestinal Stress Ameliorate Damage.Gastroenterology2021
33636438Deciphering structural bases of intestinal and hepatic selectivity in targeting pregnane X receptor with indole-based microbial mimics.Bioorg Chem2021
34688375A step towards informed positioning of advanced therapies for moderate-to-severe Crohn's disease.Lancet Gastroenterol Hepatol2021
34102340No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.Clin Gastroenterol Hepatol2021
33252119Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease.Inflamm Bowel Dis2021
32617771Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications.Dig Dis Sci2021
32812050Finding a Needle in the Haystack? Defining the Role of Random Biopsies in IBD Dysplasia Surveillance.Inflamm Bowel Dis2021
31504545Predictors of Perianal Fistula Relapse in Crohn's Disease.Inflamm Bowel Dis2020
36777752Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease.Crohns Colitis 3602020
32062041Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.Clin Gastroenterol Hepatol2020
31851091Incident heart failure is a predictor of adverse outcomes in inflammatory bowel disease.Eur J Gastroenterol Hepatol2020
32656800Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease.Aliment Pharmacol Ther2020
32367294Defining the phenotype, pathogenesis and treatment of Crohn's disease associated spondyloarthritis.J Gastroenterol2020
30663075Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors.Aliment Pharmacol Ther2019
31686385Vaccination in the Elderly and IBD.Curr Treat Options Gastroenterol2019
30098947Intestinal Spirochetosis Resembles Inflammatory Bowel Disease in a Patient With HIV Infection.Clin Gastroenterol Hepatol2019
31050734Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes.Inflamm Bowel Dis2019
30268561Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.Clin Gastroenterol Hepatol2019
30625408Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.Clin Gastroenterol Hepatol2019
30312400Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.Inflamm Bowel Dis2019
29788240Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.Inflamm Bowel Dis2018
29946178Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.Am J Gastroenterol2018
29857091Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.Gastroenterology2018
29876742Helicobacter pylori is associated with increased risk of serrated colonic polyps: Analysis of serrated polyp risk factors.Indian J Gastroenterol2018
30390030Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.Am J Gastroenterol2018
27865717Eosinophilic esophagitis as possible complication of aspirin treatment in patient with aspirin-exacerbated respiratory disease.Ann Allergy Asthma Immunol2017
27296941The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium.Am J Gastroenterol2016
26247164Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents.Clin Gastroenterol Hepatol2016
27942535Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity.Nucl Receptor Res2016
  • 1 - 50 of 57

Recommended Authors

Sunhee Park
University of California Irvine
Career Start Year 2014
Number of shared co-authors 5
Terrence C Lee
University of California San Diego
Career Start Year 2013
Number of shared co-authors 0
Vivek A Rudrapatna
University of California san francisco
Career Start Year 2012
Number of shared co-authors 5
Phillip Gu
Cedars-Sinai Medical Center
Career Start Year 2012
Number of shared co-authors 5
Gaurav Syal
university of california san diego
Career Start Year 2012
Number of shared co-authors 9
Christina Ha
Cedars-Sinai Medical Center
Career Start Year 2009
Number of shared co-authors 8
Joseph J Larson
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 1
Brendan Boyle
Nationwide Children's Hospital
Career Start Year 2009
Number of shared co-authors 0
Shailja C Shah
University of California San Diego, Veterans Affairs San Diego Healthcare System
Career Start Year 2009
Number of shared co-authors 5
Berkeley N Limketkai
university of california los angeles School of Medicine
Career Start Year 2008
Number of shared co-authors 7
Jessica J Lee
Center for Drug Evaluation and Research
Career Start Year 2006
Number of shared co-authors 0
Daniel J Stein
Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 0
Harry Sokol
Paris Center for Microbiome Medicine
Career Start Year 2004
Number of shared co-authors 2
Martijn G H van Oijen
University of Amsterdam, Cancer Center Amsterdam
Career Start Year 2004
Number of shared co-authors 0
Ashish Atreja
Icahn School of Medicine at Mount Sinai
Career Start Year 2003
Number of shared co-authors 7
Nimisha K Parekh
University of California Irvine
Career Start Year 2001
Number of shared co-authors 8
Gil Y Melmed
F. Widjaja Inflammatory Bowel Disease Institute
Career Start Year 2001
Number of shared co-authors 11
Uma Mahadevan
University of California San Francisco
Career Start Year 2000
Number of shared co-authors 10
William A Faubion
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 7
Brennan M R Spiegel
Cedars-Sinai Center for Outcomes Research and Education (CS-CORE)
Career Start Year 1992
Number of shared co-authors 5
Kevin P Rioux
University of Calgary, 0 Hospital Drive NW
Career Start Year 1992
Number of shared co-authors 0
Joseph A Murray
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 7
Nghia H Nguyen
University of California
Career Start Year 1990
Number of shared co-authors 7
Ramnik J Xavier
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 7
Dermot P B McGovern
F. Widjaja Inflammatory Bowel Disease Institute
Career Start Year 1987
Number of shared co-authors 10
Felicity T Enders
Mayo Clinic
Career Start Year 1985
Number of shared co-authors 4
Athos Bousvaros
Boston Children's Hospital
Career Start Year 1985
Number of shared co-authors 2
Samuel B Ho
College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences
Career Start Year 1983
Number of shared co-authors 4
Phillip Fleshner
F. Widjaja Inflammatory Bowel Disease Institute
Career Start Year 1981
Number of shared co-authors 11
Ryan Balfour Sartor
University of North Carolina at Chapel Hill
Career Start Year 1981
Number of shared co-authors 5

Collaborators

Jean-Frederic Colombel
Icahn School of Medicine at Mount Sinai
Co-authored papers 17
David Hudesman
NYU Grossman School of Medicine
Co-authored papers 15
Corey A Siegel
Dartmouth-Hitchcock Medical Center
Co-authored papers 14
Arun Swaminath
Lenox Hill Hospital
Co-authored papers 13
Parambir S Dulai
Feinberg School of Medicine Northwestern University
Co-authored papers 13
Sunanda V Kane
Mayo Clinic
Co-authored papers 12
William J Sandborn
University of California San Diego
Co-authored papers 12
Bruce E Sands
Icahn School of Medicine at Mount Sinai
Co-authored papers 12
Brigid S Boland
University of California
Co-authored papers 12
Edward V Loftus
Mayo Clinic College of Medicine and Science
Co-authored papers 12
Siddharth Singh
University of California San Diego
Co-authored papers 11
Robert Hirten
Co-authored papers 11
Eugenia Shmidt
University of Minnesota
Co-authored papers 11
Farhad Peerani
University of Alberta
Co-authored papers 5
Khadija Chaudrey
Lahey Hospital and Medical Center
Co-authored papers 5
Neeraj Narula
Farncombe Family Digestive Health Research Institute, McMaster University
Co-authored papers 5
Diana Whitehead
Dartmouth-Hitchcock Medical Center
Co-authored papers 4
Vipul Jairath
Schulich school of Medicine, Western University.
Co-authored papers 4
John T Chang
University of California San Diego
Co-authored papers 3
Ronghui Xu
University of California San Diego
Co-authored papers 2
Ashwin N Ananthakrishnan
Co-authored papers 2
Timothy C Wang
Division of Gastroenterology and Irvine Cancer Research Center, Columbia University
Co-authored papers 1
Daniel B Kearns
Indiana University
Co-authored papers 1
Xiaoqian Jiang
Carnegie Mellon University, The University of Texas Health Science Center at Houston, University of California San Diego
Co-authored papers 1
Paul Zumbo
Co-authored papers 1
Marla C Dubinsky
Co-authored papers 1
Olivier Elemento
Meyer Cancer Center
Co-authored papers 1
Jenny Sauk
university of california los angeles School of Medicine
Co-authored papers 1
Lina Jandorf
Co-authored papers 1
Shuang Wang
Shanghai Putuo People's Hospital, Tongji University
Co-authored papers 1
Release 1.2